Table 3.
Association between clinicopathological parameters and COMP expression
| Parameters | n | COMP expression | P value | |||
|---|---|---|---|---|---|---|
| Negative (n=3) (%) | Weak (n=19) (%) | Positive (n=20) (%) | Strong (n=16) (%) | |||
| Age (years) | 0.212 | |||||
| <45 | 25 | 3 (12.0) | 8 (32.0) | 7 (28.0) | 7 (28.0) | |
| ≥45 | 33 | 0 (0.0) | 11 (33.3) | 13 (39.4) | 9 (27.3) | |
| Gender | 0.942 | |||||
| Male | 23 | 1 (4.3) | 8 (34.8) | 7 (30.4) | 7 (30.4) | |
| Female | 35 | 2 (5.7) | 11 (31.4) | 13 (37.1) | 9 (25.7) | |
| Size | 0.320 | |||||
| ≤2 cm | 23 | 2 (8.7) | 10 (43.5) | 6 (26.1) | 5 (21.7) | |
| >2 cm | 35 | 1 (2.9) | 9 (25.7) | 14 (40.0) | 11 (31.4) | |
| Location | 0.614 | |||||
| Left | 25 | 2 (8.0) | 7 (28.0) | 10 (40.0) | 6 (24.0) | |
| Right | 23 | 1 (4.3) | 9 (39.1) | 8 (34.8) | 5 (21.7) | |
| Bilateral | 10 | 0 (0.0) | 3 (30.0) | 2 (20.0) | 5 (50.0) | |
| Lymph node invasion | 0.038* | |||||
| Negative | 44 | 3 (6.8) | 16 (36.4) | 17 (38.6) | 8 (18.2) | |
| Positive | 14 | 0 (0.0) | 3 (21.4) | 3 (21.4) | 8 (57.1) | |
| T stage | 0.964 | |||||
| T1 | 32 | 2 (6.3) | 11 (34.4) | 10 (31.3) | 9 (28.1) | |
| T2 | 22 | 1 (4.5) | 6 (27.3) | 9 (40.9) | 6 (27.3) | |
| T3 | 2 | 0 (0.0) | 1 (50.0) | 1 (50.0) | 0 (0.0) | |
| T4 | 2 | 0 (0.0) | 1 (50.0) | 0 (0.0) | 1 (50.0) | |
| N stage | 0.363 | |||||
| N0 | 31 | 2 (6.5) | 7 (22.6) | 12 (38.7) | 10 (32.3) | |
| N1 | 27 | 1 (3.7) | 12 (44.4) | 8 (29.6) | 6 (22.2) | |
| AJCC stage | 0.579 | |||||
| I-II | 38 | 3 (7.9) | 12 (31.6) | 12 (31.6) | 11 (28.9) | |
| III-IV | 20 | 0 (0.0) | 7 (35.0) | 8 (40.0) | 5 (25.0) | |
Pearson chi-square test.
*P < 0.05 indicates a significant association among the variables.